Gil Redelman-Sidi

6PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyPredictive and prognostic markersInnate immunityCybercrime
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 02, 2024
Microbial cancer immunotherapy reprograms hematopoietic stem cells to enhance anti-tumor immunity.

Andrew W Daman, Anthony C Antonelli, Gil Redelman-Sidi

|Aug 30, 2022
BCG-Induced Tumor Immunity Requires Tumor-Intrinsic CIITA Independent of MHC-II.

Gil Redelman-Sidi, Anna Binyamin, Anthony C Antonelli

|Jul 09, 2022
BCG in Bladder Cancer Immunotherapy.

Song Jiang, Gil Redelman-Sidi

|Aug 16, 2020
Recommendations for Testing and Treating Outpatient Cancer Patients in the Era of COVID-19.

Diane Reidy-Lagunes, Leonard Saltz, Michael Postow

|Jul 19, 2020
Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling.

Anthony C Antonelli, Anna Binyamin, Tobias M Hohl

|Apr 29, 2020
Could BCG be used to protect against COVID-19?

Gil Redelman-Sidi

Pageof 1

Frequent Collaborators

3 joint publications

Anthony C Antonelli

3 joint publications

Michael S Glickman

2 joint publications

Anna Binyamin

1 joint publications

Tobias M Hohl